Oncology Venture – First day of trading in investor warrants

NEXT STORY
Two Decades Of Value Delivery And Partnership In Mali
PREV STORY
ImCheck Therapeutics appoints Paul Frohna MD, PhD, PharmD,as Chief Medical Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Merus to Present at the 2017 Wedbush PacGrow Healthcare Conference

UTRECHT, The Netherlands, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage ...

author_avatar
NASDAQ Market News

Multiple New Studies Demonstrate T2 Biosystems’ Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics

LEXINGTON, Mass., March 28, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging ...

author_avatar
NASDAQ Market News

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LEXINGTON, Mass., Jan. 06, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company ...

author_avatar
NASDAQ Market News